Materion Corp

This advisory (non-binding) proposal asks shareholders to approve the Company’s named executive officer (NEO) compensation as disclosed in the proxy, including the Compensation Discussion and Analysis and compensation tables. Management seeks shareholder endorsement to confirm that its pay-for-performance framework and recent compensation decisions are consistent with shareholder interests; the Compensation Committee emphasizes that a substantial portion of executive pay is at-risk and equity-based (SARs, RTSR and ROIC PRSUs, RSUs) to align executives with long-term value creation. Contextually, the Company reported 0% annual incentive payouts for 2025 due to below-threshold performance on adjusted EBIT, value-added sales growth and simplified free cash flow, while long-term performance PRSUs have exhibited variable funding (for example, strong RTSR outcomes funded at 200% for 2023 grants). Management highlights governance safeguards—stock ownership guidelines, retention/holding requirements, clawback policies, double-trigger change-in-control provisions, and independent consultant oversight—to mitigate misalignment and excessive risk-taking. The advisory vote is non-binding, but the Compensation Committee will review results and consider them in future program design; historically the Company received strong shareholder support (over 95% approval at the 2025 meeting). Potential shareholder concerns include realized pay levels driven by equity appreciation and the use of multi-year performance metrics; critics may press for greater disclosure on target-setting, peer group choice for RTSR, or stronger linkages to ESG or other non-financial metrics. Given the Company’s explicit pay-for-performance orientation and the Committee’s responsiveness to shareholder feedback, a FOR vote signals support for current program design but does not limit future recalibration by the Board. The Board’s recommendation and the Company’s governance practices suggest management expects continued shareholder backing, but the non-binding nature means investors can use the vote to influence future compensation structures without directly changing pay this year.

This management proposal requests shareholder approval to amend Article X of the Company’s Amended and Restated Articles of Incorporation to change the board size range from a minimum of nine and maximum of 18 directors to a minimum of seven and maximum of 15 directors. Management argues the change grants the Board flexibility to right-size the Board to meet evolving strategic and oversight needs and brings the Company in line with peer practices; the Board asserts that a maximum of 15 directors is a practical range and that 16–18 would be unusually large for its peer group. From a governance perspective, the proposal is structurally simple but material because it changes a fundamental charter parameter; approval requires a majority of outstanding shares (a higher standard than a majority of votes cast), meaning abstentions and broker non-votes will effectively count against adoption. Potential benefits include improved meeting efficiency, streamlined decision-making, and easier alignment of skills to strategic priorities; potential downsides include reduced committee capacity, fewer seats for independent or diverse directors, and the risk that reducing the absolute board headcount could concentrate power among fewer insiders. The timing suggests management seeks to preserve flexibility after a recent board retirement and one new appointment, enabling the Board to calibrate composition without needing a charter amendment for each change. For activists or large shareholders, this amendment can be benign or positive if it is paired with robust director selection and refreshment practices; conversely, it could be viewed skeptically if shareholders fear entrenchment or diminished oversight. Given the Board’s unanimous recommendation and the Company’s stated governance practices (majority voting policy, independent committees, board skills matrix), the net governance risk depends on how the Board uses the flexibility: exercised to refine and strengthen expertise it is likely value-accretive, whereas arbitrary reductions could harm oversight. Investors should evaluate the proposal in the context of the Company’s recent board composition, succession plans, and the Board’s commitment to independence and diversity.